The pathogenicity of the fungus Geotrichum candidum in humans has not been clearly defined. A patient with acute leukemia who developed a fatal disseminated G. candidum infection while neutropenic is described. At autopsy examination, this patient was misdiagnosed on the basis of histopathology as having disseminated candidiasis until G. candidum was isolated from postmortem culture specimens. The emergence of this organism as an occasional pathogen in leukemic patients is of interest and illustrates the importance of obtaining fungal cultures. There is a need for more effective drugs for antifungal prophylaxis and therapy.
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Geotrichum candidum is a ubiquitous fungus which is rarely pathogenic in humans. Only one case of disseminated infection has been described previously, and its significance has been questioned (4, 8 (8) . Only one patient with a disseminated infection caused by G. candidum has been described previously. The significance of this particular case was questioned, however, and culture documentation of NOTES widespread G. candidum infection was not presented (4, 8) . Evidence for dissemination in six other reported cases is lacking (1, 5, 7, 10, 11 The efficacy of amphotericin B in G. candidum infections is difficult to assess in view of the small number of patients treated. The presence of severe granulocytopenia in our patient probably contributed to her fatal outcome (3). Another determining factor could be whether the organism is susceptible to the antifungal agent administered. Data concerning such in vitro susceptibility are scanty. The organism seems to be susceptible, however, to amphotericin B and miconazole (2, 9) .
Although rare, G. candidum is a potential pathogen in immunocompromised hosts. Its incidence may be underreported, since it can be misdiagnosed histopathologically as Candida sp., Aspergillus sp., or Trichosporon sp. This possibility for misdiagnosis illustrates the importance of obtaining fungal cultures in addition to histopathological data. Better awareness of its pathogenicity could delineate its true incidence, patterns of clinical disease, and responsiveness to therapy.
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